← Back to Vaccine Database

Gardasil

Subunit vaccine · VDDBV0282

Target & Classification

HPVHuman papillomavirus
Subunit vaccine
Human Papillomavirus; Sexual Transmission of Infection; Cervical Cancer; Genital Warts; HPV; Cancer of Cervix; Cervical Cancer; HPV Infection; Vaccine Preventable Disease; HPV Infection; Papillomavirus Infections; Chronic Kidney Disease; Systemic Lupus Erythematosus; Complication of Transplanted Liver; Human Papillomavirus-Related Carcinoma; HPV 16 Infection; Transplantation; Systemic Lupus Erythematosus; Systemic Immune Disease; Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis; Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Poliomyelitis; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus Infection; HPV-Related Malignancy; Human Papilloma Virus; Human Papillomavirus Vaccines; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HIV-1-infection; HPV Infection; Cervical Cancers; Vulvar Cancer; Vaginal Cancer; Anal Intraepithelial Neoplasia; Anal Cancer; Human Papilloma Virus; HPV Infections; Cervical Cancer; Human Papilloma Virus; Hiv; Organ Transplants; Immunization; Efficacy; Human Papilloma Virus; Cervical Cancer; Vulvar Cancer; Human Papillomavirus Vaccine; Genital Warts; HPV Infections; Cancer Survivor; Prevention of Human Papillomavirus Infection; Papillomavirus Infection; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Cervical Cancer; Nonneoplastic Condition; Precancerous Condition; Anal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition; Human Papillomavirus-Related Cervical Carcinoma; Quadrivalent HPV Vaccine; Human Papillomavirus Vaccine; Human Papillomavirus Infection; Cervical Cancer; Condylomata Acuminata; Infections, Meningococcal; Infections, Papillomavirus; HPV 16- and; or HPV 18-Infected Women With Normal Cytology; Cervical Intraepithelial Neoplasia; Cervical Intraepithelial Neoplasia 3; Head and Neck Squamous Cell Carcinoma; HPV-Related Squamous Cell Carcinoma; HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer; Head and Neck Cancer
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials62

Note: 13 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT01133509 —Human Papillomavirus
NCT02087384 ApprovedSexual Transmission of Infection
NCT00666107 —Cervical Cancer; Genital Warts
NCT00964210 Phase 3HPV
NCT00923702 ApprovedCancer of Cervix
NCT01338051 Phase 1Cervical Cancer
NCT01021904 ApprovedHPV Infection; Vaccine Preventable Disease
NCT00260039 Phase 2HPV Infection
NCT00798265 Phase 1Papillomavirus Infections
NCT01432574 Phase 2Chronic Kidney Disease
NCT00925288 ApprovedSystemic Lupus Erythematosus
NCT00513526 Phase 2Complication of Transplanted Liver; Human Papillomavirus-Related Carcinoma
NCT00786409 —Cervical Cancer; Genital Warts
NCT00727636 —HPV 16 Infection
NCT01456715 Phase 3Transplantation; Systemic Lupus Erythematosus; Systemic Immune Disease
NCT01489527 —Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
NCT00092534 Phase 3Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Poliomyelitis
NCT05031078 ApprovedCervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Warts; Human Papillomavirus Infection
NCT05149248 Phase 3HPV-Related Malignancy
NCT01173900 ApprovedHuman Papilloma Virus
NCT04953130 ApprovedHPV Infection
NCT04590521 ApprovedHuman Papillomavirus Vaccines
NCT00157950 Phase 3HPV Positive Oropharyngeal Squamous Cell Carcinoma; HIV-1-infection; HPV Infection
NCT00806676 —Cervical Cancers; Vulvar Cancer; Vaginal Cancer
NCT00911521 ApprovedAnal Intraepithelial Neoplasia; Anal Cancer; Human Papilloma Virus
NCT02624349 ApprovedHPV Infections; Cervical Cancer
NCT00501137 Phase 3Human Papilloma Virus
NCT00365378 Phase 2Human Papilloma Virus; Hiv; Organ Transplants
NCT01687192 Phase 2Immunization; Efficacy; Human Papilloma Virus
NCT00325130 Phase 3Cervical Cancer; Vulvar Cancer
NCT00337428 Phase 3Human Papillomavirus Vaccine
NCT00543543 Phase 3Genital Warts
NCT02576054 Phase 3HPV Infections
NCT01862874 Phase 3HPV Infections
NCT01544478 ApprovedPapillomavirus Infections
NCT00092495 Phase 3Papillomavirus Infections
NCT00092482 Phase 3HPV Infections
NCT00517309 Phase 3Cancer Survivor; Prevention of Human Papillomavirus Infection
NCT00092521 Phase 3Papillomavirus Infection; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
NCT00092547 Phase 3HPV Infections
NCT03493542 Phase 3HPV Infections
NCT00365716 Phase 2Cervical Cancer; Nonneoplastic Condition; Precancerous Condition
NCT01101750 ApprovedAnal Cancer; Nonneoplastic Condition; Penile Cancer; Precancerous Condition
NCT01512784 Phase 3Human Papillomavirus-Related Cervical Carcinoma
NCT00496626 Phase 3Human Papilloma Virus
NCT00524745 —Quadrivalent HPV Vaccine; Human Papillomavirus Vaccine
NCT00635830 Phase 1Human Papillomavirus Infection
NCT00733122 Phase 3Cervical Cancer; Condylomata Acuminata
NCT00380367 Phase 3Infections, Meningococcal
NCT01245764 Phase 3Infections, Papillomavirus
NCT00411749 Phase 2HPV 16- and; or HPV 18-Infected Women With Normal Cytology
NCT01492582 Phase 2Cervical Intraepithelial Neoplasia
NCT00090220 Phase 3Cervical Intraepithelial Neoplasia
NCT00378560 Phase 2Cervical Intraepithelial Neoplasia 3
NCT00834106 Phase 3Cervical Cancer
NCT00667563 Phase 1Head and Neck Squamous Cell Carcinoma
NCT01209325 Phase 2HPV-Related Squamous Cell Carcinoma
NCT03728881 Phase 3HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
NCT02382900 Phase 3Human Papilloma Virus
NCT01184079 —Human Papillomavirus
NCT00572832 —Cervical Cancer
NCT04782895 Phase 3Head and Neck Cancer